The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Strategic patent counseling services to Red Hat Inc.
Provides strategic patent counseling services to Red Hat Inc., the most recognized open-source software company in the world. Analyzes and more
Equity Committee for SageCrest II LLC
Representation of the Official Committee of Equity Security Holders of SageCrest II LLC in Chapter 11 cases pending in the Bankruptcy Court for more
Outsourcing for a major credit card and check verification company
Represented a major credit card and check verification company with respect to credit card processing, call centers and back office support to two more
Employment litigation alleging sexual harassment and retaliation for a chemical manufacturer
Represented a chemical manufacturer in lawsuit brought by a former employee alleging sexual harassment and retaliation, culminating in her more